Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001193805-25-000923
Filing Date
2025-06-20
Accepted
2025-06-20 17:15:45
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 e664638_4a-vitt.html 4/A  
1 e664638_4a-vitt.xml 4/A 7036
  Complete submission text file 0001193805-25-000923.txt   8570
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address IMMUNIC AG AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address
Vitt Daniel (Reporting) CIK: 0001773673 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36201 | Film No.: 251062299